Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Itakura

Showing results (101-110 of 123) with videos related to

Pageof 13
Sort By:
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|December 15, 2020
Early radiological response evaluation with response evaluation criteria in solid tumors 1.1 stratifies survival in hepatocellular carcinoma patients treated with lenvatinibShun Kaneko, Kaoru Tsuchiya, Yutaka Yasui, et al.
Journal of Gastroenterology and Hepatology|January 25, 2020
Validation of hepatocellular carcinoma risk scores in Japanese chronic hepatitis B cohort receiving nucleot(s)ide analogSakura Kirino, Nobuharu Tamaki, Shun Kaneko, et al.
Cancers|October 12, 2019
Sorafenib-Regorafenib Sequential Therapy in Japanese Patients with Unresectable Hepatocellular Carcinoma-Relative Dose Intensity and Post-Regorafenib Therapies in Real World PracticeWan Wang, Kaoru Tsuchiya, Masayuki Kurosaki, et al.
Plos One|April 25, 2014
Distinct cell clusters touching islet cells induce islet cell replication in association with over-expression of Regenerating Gene (REG) protein in fulminant type 1 diabetesKaoru Aida, Sei Saitoh, Yoriko Nishida, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 27, 2017
Up-to-seven criteria as a useful predictor for tumor downstaging to within Milan criteria and Child-Pugh grade deterioration after initial conventional transarterial chemoembolizationYutaka Yasui, Kaoru Tsuchiya, Masayuki Kurosaki, et al.
Anticancer Research|November 7, 2018
Feasibility of Combination Therapy with Nab-paclitaxel Plus Gemcitabine in Patients with Recurrent Pancreatic CancerHiromichi Kawaida, Hiroshi Kono, Hidetake Amemiya, et al.
Journal of Gastroenterology|April 8, 2018
Real-world efficacy and safety of ledipasvir and sofosbuvir in patients with hepatitis C virus genotype 1 infection: a nationwide multicenter study by the Japanese Red Cross Liver Study GroupKeiji Tsuji, Masayuki Kurosaki, Jun Itakura, et al.
Anticancer Research|December 8, 2019
Stratification of Prognosis in Patients With Ampullary Carcinoma After Surgery by Preoperative Platelet-to-lymphocyte Ratio and Conventional Tumor MarkersHiromichi Kawaida, Hiroshi Kono, Hidetake Amemiya, et al.
Digestive Diseases (Basel, Switzerland)|August 4, 2021
Plasma Renin Activity Predicts Prognosis and Liver Disease-Related Events in Liver Cirrhosis Patients with Ascites Treated by TolvaptanLeona Osawa, Hiroyuki Nakanishi, Masayuki Kurosaki, et al.
Antiviral Therapy|August 6, 2011
Relationship between polymorphisms of the inosine triphosphatase gene and anaemia or outcome after treatment with pegylated interferon and ribavirinMasayuki Kurosaki, Yasuhito Tanaka, Keisuke Tanaka, et al.
Pageof 13

Showing results (101-110 of 123) with videos related to

Sort By:
Pageof 13
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|December 15, 2020
Early radiological response evaluation with response evaluation criteria in solid tumors 1.1 stratifies survival in hepatocellular carcinoma patients treated with lenvatinibShun Kaneko, Kaoru Tsuchiya, Yutaka Yasui, et al.
Journal of Gastroenterology and Hepatology|January 25, 2020
Validation of hepatocellular carcinoma risk scores in Japanese chronic hepatitis B cohort receiving nucleot(s)ide analogSakura Kirino, Nobuharu Tamaki, Shun Kaneko, et al.
Cancers|October 12, 2019
Sorafenib-Regorafenib Sequential Therapy in Japanese Patients with Unresectable Hepatocellular Carcinoma-Relative Dose Intensity and Post-Regorafenib Therapies in Real World PracticeWan Wang, Kaoru Tsuchiya, Masayuki Kurosaki, et al.
Plos One|April 25, 2014
Distinct cell clusters touching islet cells induce islet cell replication in association with over-expression of Regenerating Gene (REG) protein in fulminant type 1 diabetesKaoru Aida, Sei Saitoh, Yoriko Nishida, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 27, 2017
Up-to-seven criteria as a useful predictor for tumor downstaging to within Milan criteria and Child-Pugh grade deterioration after initial conventional transarterial chemoembolizationYutaka Yasui, Kaoru Tsuchiya, Masayuki Kurosaki, et al.
Anticancer Research|November 7, 2018
Feasibility of Combination Therapy with Nab-paclitaxel Plus Gemcitabine in Patients with Recurrent Pancreatic CancerHiromichi Kawaida, Hiroshi Kono, Hidetake Amemiya, et al.
Journal of Gastroenterology|April 8, 2018
Real-world efficacy and safety of ledipasvir and sofosbuvir in patients with hepatitis C virus genotype 1 infection: a nationwide multicenter study by the Japanese Red Cross Liver Study GroupKeiji Tsuji, Masayuki Kurosaki, Jun Itakura, et al.
Anticancer Research|December 8, 2019
Stratification of Prognosis in Patients With Ampullary Carcinoma After Surgery by Preoperative Platelet-to-lymphocyte Ratio and Conventional Tumor MarkersHiromichi Kawaida, Hiroshi Kono, Hidetake Amemiya, et al.
Digestive Diseases (Basel, Switzerland)|August 4, 2021
Plasma Renin Activity Predicts Prognosis and Liver Disease-Related Events in Liver Cirrhosis Patients with Ascites Treated by TolvaptanLeona Osawa, Hiroyuki Nakanishi, Masayuki Kurosaki, et al.
Antiviral Therapy|August 6, 2011
Relationship between polymorphisms of the inosine triphosphatase gene and anaemia or outcome after treatment with pegylated interferon and ribavirinMasayuki Kurosaki, Yasuhito Tanaka, Keisuke Tanaka, et al.
Pageof 13